Working… Menu

Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02461719
Recruitment Status : Completed
First Posted : June 3, 2015
Last Update Posted : June 3, 2015
Information provided by (Responsible Party):
Taejoon Pharmaceutical Co., Ltd.

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : September 2014
Actual Study Completion Date : October 2014
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 June 8, 2015
June 15, 2015
2 June 22, 2015
July 21, 2015
3 July 21, 2015
August 17, 2015